3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Burkitt Lymphoma
1
Interventions
Carboplatin
30
pembrolizumab
25
Pemetrexed
25
Specimen Handling
23
Cisplatin
21
Magnetic Resonance Spectroscopy
19
Paclitaxel
14
Gemcitabine
14
Docetaxel
11
durvalumab
8
Nivolumab
8
osimertinib
7
atezolizumab
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
Platinum
6
Cetuximab
6
1,2-diaminocyclohexaneplatinum II citrate
6
Radiation
5
Etoposide
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiosurgery
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Cyclosporins
×
30 days
×
Clear all
No trials found.